Consistent with these data, our findings revealed that DKK4 suppresses tumorigenesis of human HCC cells in vivo, whereas shRNA-mediated inhibition of DKK4 accelerated tumorigenesis (Fig 3D–3F, Fig 5B and 5F). The gene discussed is DKK4; the disease is hepatocellular carcinoma.